PHARMAID

Pharmaids Pharmaceuticals Ltd.

29.00+0.5 (+1.75%)
23 Oct, 12:00 AM

Annual Reports and Financial Documents

Pharmaids Pharmaceuticals Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
20132014201520162017201820192020202120222023202420252026
Annual ReportsFY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Quarterly Results—————
Conference Calls——————————————
Presentations——————————————

Corporate Announcements and Regulatory Filings

Pharmaids Pharmaceuticals Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. Newspaper Publication15 Oct 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper publication regarding Special Window for re-lodgement of transfer request of physical shares
  2. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201813 Oct 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter and half year ended September 30, 2026.
  3. Closure of Trading Window25 Sept 2026
    Closure of Trading Window
    Intimation w.r.t Closure of Trading Window
  4. General16 Sept 2026
    Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
    Pursuant to the Regulation 30(3) & 30(4) read with Para B of Part A of Schedule III of SEBI (Listing Obligations and Disclosure requirements) Regulations 2015, we hereby inform that the ....
  5. AGM15 Sept 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
    Voting Results along with the Scrutinizer''s Report of the 37th AGM of the Company held on 11th September 2026 through VC/ OAVM.
  6. AGM11 Sept 2026
    Shareholder Meeting / Postal Ballot-Outcome of AGM
    Outcome of the 37th Annual General Meeting of the Company held on September 11, 2026 i.e., today at 12 noon through VC/OAVM.
  7. Newspaper Publication19 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Enclosed copies of Newspaper Advertisement published on August 19, 2026 intimating the Notice of 37th Annual General Meeting of the Company
  8. Reg. 34 (1) Annual Report18 Aug 2026
    Reg. 34 (1) Annual Report.
    Annual Report
  9. AGM18 Aug 2026
    Notice Of 37Th Annual General Meeting And Annual Report
    Notice of 37th AGM and Annual Report
  10. Newspaper Publication14 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper publication of unaudited financial results (standalone & consolidated) for the quarter ended June 30, 2026
  11. Outcome of Board Meeting12 Aug 2026
    Board Meeting Outcome for Board Meeting Outcome For August 12, 2026
    Outcome of the Board meeting held today i.e. August 12, 2026
  12. Board Meeting6 Aug 2026
    Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended 30Th June 2026.
    Pharmaids Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve the Unaudited Financial ....
  13. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20187 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate under Regulation 74(5) of the SEBI (Depositaries and Participants) Regulations, 2018 for the quarter ended June 30, 2026.
  14. Change in Management30 Jun 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Appointment of M/s. V Mahendra & Associates, as the Internal Auditors of the Company for carrying out the Internal Audit for the financial year 2026-27.
  15. Closure of Trading Window26 Jun 2026
    Closure of Trading Window
    Intimation w.r.t Closure of Trading Window
  16. Change in Management25 Jun 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we wish to inform you of the change in Senior Management Personnel ....
  17. General13 Jun 2026
    Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015-Providing Corporate Guarantee To Subsidiary
    Announcement under Regulation 30 of SEBI (LODR) Regulations, 2015 - Providing corporate guarantee to subsidiary, Adita Bio Sys Private Limited
  18. Newspaper Publication31 May 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper publication of Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31, 2026
  19. Outcome of Board Meeting29 May 2026
    Board Meeting Outcome for Board Meeting Outcome For Audited Financial Results For The Quarter And Year Ended March 31, 2026
    The Board of Directors of the Company have approved the Audited Financial Results for the quarter and year ended March 31, 2026 at their meeting held on May 29, 2026.
  20. Board Meeting22 May 2026
    Board Meeting Intimation for Consideration And Approval Of Audited Financial Results (Standalone And Consolidated) For The Quarter And Year Ended 31St March 2026.
    Pharmaids Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve the Audited Financial ....

Frequently Asked Questions

Where can I download the annual report of Pharmaids Pharmaceuticals Ltd.?
Annual reports of Pharmaids Pharmaceuticals Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Pharmaids Pharmaceuticals Ltd.?
Quarterly earnings results and presentations of Pharmaids Pharmaceuticals Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Pharmaids Pharmaceuticals Ltd. publish earnings call transcripts?
Earnings call transcripts of Pharmaids Pharmaceuticals Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Pharmaids Pharmaceuticals Ltd.?
Investor presentations and annual day presentations of Pharmaids Pharmaceuticals Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Pharmaids Pharmaceuticals Ltd.?
Corporate announcements and regulatory filings of Pharmaids Pharmaceuticals Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Pharmaids Pharmaceuticals Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Pharmaids Pharmaceuticals Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Pharmaids Pharmaceuticals Ltd.?
The ISIN (International Securities Identification Number) of Pharmaids Pharmaceuticals Ltd. is INE117D01018. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Pharmaids Pharmaceuticals Ltd. listed?
Pharmaids Pharmaceuticals Ltd. is listed on NSE and BSE. The NSE symbol is PHARMAID and the BSE code is -.
Where can I find the shareholding pattern of Pharmaids Pharmaceuticals Ltd.?
The quarterly shareholding pattern of Pharmaids Pharmaceuticals Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Pharmaids Pharmaceuticals Ltd. on Sharpely?
Share price data for Pharmaids Pharmaceuticals Ltd. is updated as of 23 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.